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Abstract

Stroke is a common and serious health disorder, affecting approximately 795,000 people
in the United States every year. Intravenous recombinant tissue plasminogen activator (IV rtPA)
is the only FDA approved thrombolytic for treating acute ischemic stroke within 3 hours of
symptom onset. Patients treated at rural health centers are often transported within hours to the
closest primary stroke center. The purpose of this study was to evaluate the structure, process
and outcomes related to the inter-facility transport of ischemic stroke patients treated with
intravenous rtPA. The Quality-Caring Model© was the guiding framework.
A quantitative, retrospective, non-experimental analysis of inter-facility transport
documentation was conducted. The study population included ischemic stroke patients treated
with intravenous rtPA at a North Carolina hospital and were subsequently transferred to the
primary stroke center. The study correlated structural and process components (type of transport,
time of transport, and adherence to protocol) in relation to patient outcomes (presence of post
rtPA intracerebral hemorrhage and discharge disposition).
The study sample size was considered too small to support statistical significance.
However, the sample demonstrated the variation in terms of age, community and transport type.
Factors associated with protocol adherence include: air medical transport, shorter transport times,
and transporting with the intravenous rtPA infusing en route. Factors associated with protocol
non-adherence include: night shift transport and transport times greater than or equal to 60
minutes. The research confirms the need for a state-wide guideline for inter-facility transport of
ischemic stroke patients treated with intravenous rtPA.

ii
Table of Contents

Abstract

i

List of Figures

iii

List of Tables

iv

List of Appendices

v

Chapter I:

Introduction

2

Chapter II:

Review of Literature

14

Chapter III:

Method

25

Chapter IV:

Results

29

Chapter V:

Discussion

38

References

42

Appendices

47

iii
List of Figures
Figure 1: Theoretical Framework Describing Protocol Adherence in Acute Stroke

9

Figure 2: Inter-facility one-way mileage

33

Figure 3: Mode of transportation by referral hospital

33

Figure 4: Protocol adherence related to transport time greater or equal to 60 minutes

34

Figure 5: Protocol adherence related to transport time less than 60 minutes

34

iv

List of Tables

Table 1: Study population demographics

30

Table 2: Referral hospital characteristics

31

Table 3: Door to Door Transport Times

33

Table 4: Transport Shift and protocol adherence

35

Table 5: Protocol adherence related to transport type

36

Table 6: Percent protocol adherence for discharge disposition

36

v
List of Appendices

Appendix A: Patient Management After rtPA Administration

47

Appendix B: Approach to Hypertension in Acute Ischemic Stroke

48

Appendix C: North Carolina EMS Protocol for suspected stroke

49

Appendix D: North Carolina EMS stroke destination plan

50

Appendix E: North Carolina EMS transport policy

51

Appendix F: North Carolina EMS Air Transport policy

52

2
Chapter I
Introduction
Statement of the Problem
Stroke is a common and serious health disorder, affecting approximately 795,000 people
in the United States every year. It is the fourth leading cause of death and a major cause of long
term disability. It is a costly disease in excess of $73 billion annually in the United States
(Alberts et al., 2011). Any intervention that could reverse or limit the effects of a stroke would
have dramatic benefits.
Ischemic stroke accounts for approximately 87 percent of all strokes and it is important to
understand that early intervention is associated with improved outcomes (Rosamond et al.,
2008). Intravenous recombinant tissue plasminogen activator (IV rtPA) is the only FDA
approved thrombolytic for treating acute ischemic stroke within the first 3 hours of symptom
onset. Its main mechanism of action is to lyse a clot that is occluding a cerebral vessel, thereby
reperfusing distal ischemic brain tissue and preventing or limiting the area of cell death (Alberts,
Felberg, Guterman & Levine, 2008).
Background/Social Significance
The efficacy of intravenous rtPA was proven in the pivotal National Institute of
Neurological Disorders and Stroke (NINDS) rtPA study, which showed improved outcomes for
patients treated within three hours of stroke onset (Khatri, Levine & Jovin, 2008). Despite
availability of rtPA since 1996, the use of IV rtPA has been limited to 2 percent - 5.2 percent of
acute ischemic stroke patients (Arora et al, 2005; Bambauer et al, 2006; Adeoye et al, 2011).
There are a number of factors that contribute to the low usage of IV rtPA. They include
avoidable and unavoidable causes. Avoidable causes include a failure of the part of the public to
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recognize signs and symptoms, to understand that stroke is a time-sensitive emergency and to
immediately access emergency medical services. A main reason for the low usage is a lack of
timely neurological coverage at small or rural hospitals (Johnson & Bakas, 2010). A 2008 North
Carolina survey of hospital-based stroke services found that nearly 20 percent of the state’s
population resided in a county without a Primary Stroke Center and without a facility that used
telephone/telemedicine support or had a standing transfer plan (Goldstein, 2010). Within the 18
county region of Western North Carolina (WNC) only one hospital is a Joint Commission
certified Primary Stroke Center and has a hospitalist neurology service. In WNC over 70 percent
of the hospitals are considered rural and five are Critical Access Hospitals. All WNC hospitals
have given IV rtPA for ischemic stroke. The Emergency Department physicians at these rural
sites administer rtPA without a neurologist on site. The neurology consultation is either by
telephone or by telemedicine. Once the rtPA is given, the patient is transferred to the Joint
Commission certified Primary Stroke Center for further evaluation, stabilization and specialized
care. Inter-facility transport is provided by the local county emergency medical services, critical
care transport or air-medical transport services.
Intracerebral hemorrhage is the principle risk factor of intravenous rtPA in ischemic
stroke patients. These hemorrhages usually occur within the first 24 hours of rtPA
administration, and can be fatal. The risk of a symptomatic intracerebral hemorrhage is
approximately 6 percent when intravenous rtPA is given within 3 hours of stroke onset (Alberts
et al, 2008). Arterial pressure during the initial 24 hours after treatment is associated with rtPA
related hemorrhagic complications. For every 10 point (also known as mm Hg or millimeter of
mercury) elevation in blood pressure in the post treatment period, the odds of secondary
hemorrhage increased by 59 percent (Butcher et al., 2010). Following rtPA administration, blood
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pressure should be closely monitored and maintained less than 180/105 mm Hg. The American
Stroke Association guidelines for the management of blood pressure after treatment with rtPA
include monitoring of the blood pressure (BP) every 15 minutes for the first 2 hours; then every
30 minutes for 6 hours; then hourly until 24 hours after treatment (Adams, et al., 2007).
Attention to management of blood pressure is critical before, during and after the administration
of rtPA (Adams, et al., 2007). Medications, such as labetelol, nicardipine, or nitroprusside, are
recommended if the BP exceeds the recommended levels (Bader & Palmer, 2006). Angioedema,
a swelling or localized edema beneath the skin surface, is another less common adverse reaction
associated with intravenous rtPA treatment occurring in 1-2 percent of intravenous rtPA treated
patients (Khatri, Levine & Jovin, 2008).
Vigilant monitoring of the rtPA treated patient is essential. Most hospitals use an
intensive care unit (ICU) for monitoring the post-rtPA patient during the subsequent 24 hours
(Bader & Palmer, 2006). It is imperative that all personnel caring for ischemic stroke patients
treated with intravenous rtPA are knowledgeable of and adhere to evidence-based guidelines.
Purpose
Tissue plasminogen activator (rtPA) is a proven intervention for acute ischemic stroke
patients, with a Class I, evidence-based recommendation from the American Heart/American
Stroke Association (Adams, et al., 2007).The benefit of intravenous rtPA in acute ischemic
stroke is strongly time-dependent (Fonarow, 2011). Telemedicine consults between stroke
specialists and community hospital emergency physicians has increased the number of ischemic
stroke patients treated with intravenous rtPA, which in turn has increased the need for interfacility transfers (Pervez, et. al., 2009, Schwamm, et al., 2009). Intracerebral hemorrhage and
angioedema are possible complications associated with intravenous rtPA that require serial
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assessments and appropriate actions to prevent adverse outcomes (Khatri, Levine & Jovin,
2008). The purpose of this study is to determine the protocol adherence rate of pre-hospital
personnel during transport of acute ischemic stroke patients treated with intravenous rtPA.
Theoretical Framework
The study of adherence to evidence based protocols will utilize the Quality-Caring Model©
developed by Joann Duffy (Duffy & Hoskins, 2003). In the Quality-Caring Model© evidencebased practice of present-day healthcare is merged with the caring processes of nursing. Caring
values, attitudes, and behaviors dominate the processes of care and establish a foundation for key
relationships. Collaborative relationships include those activities and responsibilities that nurses
share with other members of the healthcare team (Duffy, Baldwin & Matorovich, 2007).
The model places relationships at the core of the therapeutic process. Through caring
relationships, nurses interact, connect and come to know the context of patients, families and coworkers. As a result, individuals feel “cared for” and are more willing to share, work together,
change old patterns, and adhere to new regimes (Duffy, 2005).
The Quality-Caring Model© combines the evidence-based practice while simultaneously
representing nursing’s unique contribution to quality health care. According to Duffy and
Hoskins (2003) the Quality-Caring Model© is grounded in the works of Donabedian (1992) and
Watson (1985) and influenced by contributions from King (1981), Mitchell (998) and Irvine
(1998). The model reflects the trend toward evidence-based nursing practice (Duffy & Hoskins,
2003). Donabedian developed a framework in the 1980’s emphasizing a dynamic process of
improvement cycles that look at system structure, process intervention of care and the outcome
effects (Chin & Muramatsu, 2003). Structure is organizational design of how a health system
runs. Structure relates to how the culture of health professionals are utilized in the health care
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setting, the characteristics of the providers, resources, tools, and staffing ratios and patterns
(Chin & Muramatsu, 2003).
The first major component, structure, is blended with the construct, causal past, and
includes the concept, participants (Duffy & Hoskins, 2003). The central component refers to
important factors that are present prior to the delivery of health care. Such factors are present in
the participants of the model, namely for this study, the patient, the nursing staff and the interfacility transport personnel. Structural components include, but not limited to: evidence based
guidelines, organizational culture and policy, available resources, and staffing patterns. Concepts
and sub-concepts included in the structure component influence the process of care and may
directly or indirectly influence outcomes of care (Duffy & Hoskins, 2003). The structure for the
study of protocol adherence during inter-facility transport of ischemic stroke patients treated with
intravenous rtPA includes national and state guidelines and recommendations for a stroke system
of care and North Carolina Emergency Medical Services policy related to inter-facility transport.
Additional structural components will include the level of pre-hospital inter-facility personnel,
the time of day and the distance traveled.
The second major component, process, involves interventions or practices that health care
provider’s offer and is the focus of this model (Duffy & Hoskins, 2003). Caring relationships are
human interactions grounded in clinical caring processes. They incorporate physical work
(doing), interaction (being with), and relationship (knowing). Collaborative relationships include:
those activities and responsibilities that nurses share with other members of the health care team.
Professional encounters that are relationship-centered are outcomes enhancers for the patient, the
provider, and the health care system (Duffy, 2005). According to Duffy and Hoskins (2003)
Donabedian relates process to “what is being done for patients” and suggests that it is composed
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of two broad categories of activities: technical and interpersonal. Process outcomes is improved
in cycles by analyzing an improvement intervention in patient care, studying the effect of that
care and finally using that data to repeat the cycle (Chin & Muramatsu, 2003). The process is
defined by the documentation by inter-facility transport personnel during the transfer of ischemic
stroke patients treated with intravenous rtPA.
The third major component, outcomes, corresponds to the end result of health care (Duffy
& Hoskins, 2003). Two forms of outcomes are apparent: intermediate and terminal Intermediate
outcomes include goals on care plans and clinical pathways, but may also include feelings about
the health care process. Terminal outcomes are those major concepts that affect the future, such
as quality of life, costs, disease-specific variables, and satisfaction with care (Duffy & Hoskins,
2003). Outcomes are dynamic and can be continually improved. Success in outcomes is heavily
dependent on the dynamic and balanced independent and collaborative relationships that
comprise professional encounters. The outcomes for the study on protocol adherence during
inter-facility transport of ischemic stroke patients treated with intravenous rtPA will include the
reported incidence of intracerebral hemorrhage and/or angioedema and patient discharge
disposition.
The measurement of quality is based on set standards of care or criteria that are
scientifically evidenced based. Inherent in the Quality-Caring Model© is the continuous search
for evidence that care provided does in fact benefit patients (Duffy & Hoskins, 2003). Duffy’s
Quality Caring Model© is applicable for this project, as outlined in Figure 1-1. The framework
describes the structure, process and outcomes utilized to examine the inter-facility care of the
ischemic stroke patient status post treatment with intravenous rtPA. The structure is defined by
the evidence-based guidelines for post rtPA care and the personnel involved. The process is
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defined by the documentation related to procedures and resources. For the purposes of this study,
the outcomes will be defined as the analysis or findings of the study.
Significance to Nursing
Stroke is a complex disease that requires the efforts and skills of all members of the
multidisciplinary team (Summers, et al., 2009). Nurses are often responsible for the coordination
of care throughout the continuum. Optimal management of the acute ischemic stroke patient in
the emergency phase of care requires an accurate and systematic evaluation that is coordinated
and timely (Summers, et al., 2009). Nurses have a unique role in improving patient outcomes.
Adherence to evidence-based protocols can be accomplished through comprehensive planning
and preparation (Rafter & Kelly, 2011).
Theoretical assumptions
For the purposes of this study, the following assumptions will be made:
1. The structure for monitoring and evaluating the ischemic stroke patients treated with
intravenous rtPA is well defined and accepted as evidence-based care.
2. The process for inter-facility transfer of the post intravenous rtPA treated stroke patient
is not well defined; therefore, it is assumed there will be variation in the process.
3. The variation in process will have a correlation to the outcome.
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Outcome
-Incidence of adverse complication (ICH and
angioedema)
- Discharge disposition
- Association between time of day or travel
times to protocol adherence

- Correlation between level of provider and
protocol adherence

Process
-Inter-facility transfer from rural hospital to stroke
center
-Vital signs & neurological checks Q 15 minutes X 2
hours then Q 30 minutes X 6 hours post IV rtPA
- Treatment of BP < 180/105 mm Hg with
antihypertensives
- Time of day

- Distance from spoke to hub hospital

Structure
- American Stroke Association recommendations
for stroke system of care
- N.C. OEMS protocols & procedures
- Utilization of telemedicine at rural community
hospitals
- Staff levels and staffing patterns

Figure 1: Theoretical Framework Describing Protocol Adherence in Acute Stroke
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Research question
National guidelines recommend serial assessments and monitoring for all ischemic stroke
patients treated with intravenous thrombolytics (rtPA). With the advent of telemedicine rural
hospital physicians are now administering the medication and transferring the patient to the
closest stroke center. The mode of transportation includes pre-hospital paramedic county
Emergency Medical Services, critical care transport teams or air-medical transport teams. The
purpose of this study is to evaluate the protocol adherence by transport personnel. In this study
the questions to be answered are:
1. What are the demographic characteristics of the study population?
2. What is the association between travel time and adherence to protocol?
3. What is the association between time of day on adherence to protocol?
4. What is the association between type of transport agency on adherence to protocol?
5. Is there a correlation between protocol adherence and discharge disposition?
6. Is there a correlation between protocol adherence and time of completion of
intravenous rtPA?

Definition of terms
For the purposes of this study, the following definitions were utilized.
Advanced Life Support (ALS).
An advanced level of pre-hospital and inter-facility emergency care that includes basic life
support functions (including cardiopulmonary resuscitation, plus cardiac monitoring,
electrocardiography, intravenous therapy, administration of medications, drugs and solutions, use
of adjunctive medical devices, trauma care and other authorized techniques and procedures.,
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initiated for the treatment of real or potential acute life threatening conditions under the direction
of the EMS medical director (Bledsoe, Porter & Cherry, 2009).
Air medical transport.
An air medical ambulance is used for emergency medical transport of stroke patients when
either a traditional ambulance cannot reach the scene easily or quickly enough, or the patient
needs to be transported over a distance that makes air transportation the most practical transport
(Bledsoe, Porter & Cherry, 2009).
Angioedema.
An allergic reaction to intravenous rtPA is angioedema of the tongue. The occurrence rate
is less than 1 percent of all patients treated with intravenous rtPA. Practitioners should routinely
inspect the tongue and oropharynx in patients 30-45 minutes after the start of the rtPA infusion.
Recommended treatment includes antihistamines and corticosteroids (Khatri, Levine & Jovin,
2008).
Critical care emergency medical transport.
Critical care emergency medical transport is a certified program that utilizes paramedics
and registered nurses for complicated inter-facility transports. This type of program is typically
from one intensive care unit to another in specially equipped ambulances or aircraft designed to
provide a higher level of care (Bledsoe, Porter & Cherry, 2009).
Emergency Medical Services (EMS).
A type of emergency services dedicated to providing out-of-hospital acute medical care
and/or transport to definitive care, to patients with illnesses or injuries with the patient, or the
medical practitioner, believes constitutes a medical emergency. In a stroke system of care, the
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EMS also encompasses the role of moving a stroke patient from a community hospital to a stroke
center (Schwamm, et al., 2005).
Intracranial hemorrhage.
Intracranial hemorrhage (ICH) occurs when a blood vessel within the brain bursts, allowing
blood to leak inside the brain. The most common cause of ICH is high blood pressure
(hypertension). Intracranial hemorrhage is the principal risk of intravenous rtPA in stroke
patients. These hemorrhages typically occur within the first 24 hours of intravenous rtPA
administration (Caplan, 2000).
Intravenous rtPA.
The only drug approved by the Food and Drug Administration (FDA) for medical therapy
in acute ischemic stroke. Its main mechanism of action is to lyses a clot that is occluding a brain
artery, thereby reperfusion the ischemic brain tissue and preventing or limiting the area of brain
cell death (Adams, et al., 2007).
Ischemic Stroke.
Ischemic stroke occurs when an artery to the brain is blocked. The brain depends on its
arteries to bring fresh blood from the heart and lungs. The blood carries oxygen and nutrients to
the brain, and takes away carbon dioxide and cellular waste. If an artery is blocked, the brain
cells cannot make enough energy and will eventually stop working. If the artery remains blocked
for more than a few minutes, the brain cells may die. For this reason immediate medically
treatment is absolutely essential (Summers, et al., 2009).
Stroke.
Stroke is defined as an acute neurologic dysfunction of vascular origin with sudden (within
seconds) or at least rapid (within hours) occurrence of symptoms and signs corresponding to the
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involvement of focal areas in the brain. Stroke is comprised of two major subtypes. Ischemic
stroke is caused by a blockage inside an artery feeding the brain and accounts for almost 80
percent of all strokes. The remaining 20 percent of strokes are hemorrhagic caused by rupture of
an artery feeding the brain (Adams, et al., 2007).
Stroke center.
In 2000, a multidisciplinary group known as the Brain Attack Coalition (BAC) identified
evidence-based interventions known to improve the outcomes of patients sustaining acute stroke.
The BAC recommendations assisted acute care hospitals in prioritizing care for stroke patients.
The major interconnecting elements include: organized acute stroke team for rapid response to
the ED, and written care protocols for the multidisciplinary team to follow integrating evidencebased literature. The BAC efforts led to the creation of Primary Stroke Center certification by
The Joint Commission (Alberts, et al., 2011).
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Chapter II
Review of the Literature
The review of the literature will follow Duffy’s Quality-Caring Model© (2005) with a
concentration on structure, process and outcome. Stroke is a common and serious disorder. Each
year in the United States, approximately 795,000 people will have a new or recurrent stroke.
Improved care of patients with acute stroke may reduce the high morbidity and mortality from
this disorder and have significant public and financial implications (Alberts, et al., 2011). Prior
studies have shown that many patients with stroke are not treated according to contemporary
guidelines. One approach to improving stroke care is the development of Stroke Centers. These
hospitals would act as focal points for the care of patients with acute stroke. Approximately
seventy-seven percent of all US counties lack a hospital with neurological services highlights the
need for more organized and centralized stroke care (Alberts, et al., 2011).
A review of the current literature was completed using PubMed, CINAHL, MEDLINE, and
OVID databases using key words: stroke, emergency medical services, inter-facility transfer,
telemedicine, thrombolysis, guidelines and quality. The search was limited to English studies
published between 2006 and 2011. The initial search yield included forty-three position
statements and peer-reviewed studies. To date there are no published studies regarding the interfacility transport of ischemic stroke patients treated with intravenous rtPA or on the role of
Emergency Medical Services in the post treatment phase of care.
Structure
The American Heart Association/American Stroke Association publishes evidence-based
guidelines for the early management of adults with ischemic stroke every three to five years. The
latest guidelines were published in 2007. The goal is to provide an overview of the current
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evidence about components of the evaluation and treatment of adults with ischemic stroke. The
intended audience is physicians and other emergency healthcare providers who treat patients
within the first 48 hours after stroke. Members of the panel were appointed by the American
Heart Association Stroke Council’s Scientific Statement Oversight Committee and represent
different areas of expertise. The panel completes a review of the current literature with an
emphasis on the most current reports. After approval by the panel, the guidelines are peerreviewed and approved by the Committee (Adams, et al., 2007).
The availability of resources to care for patients with acute stroke varies widely both
among and within communities (Adams, et al., 2007). The National Institute of Health (NIH)
Task Force report “Improving the Chain of Recovery for Acute Stroke in Your Community,”
recommends identifying hospitals capable of providing acute stroke care and creating a transport
system to these centers based on patient location. Such systems require advance planning and
frequent updating and should incorporate EMS representatives, community leaders, hospitals,
and physicians to ensure clear guidance for EMS providers with regard to patient destination
(Adams, et al., 2007). The emphasis for EMS in the 2007 guidelines was for early recognition
and rapid transport to the closest stroke center. The authors did note that strategies such as
telemedicine or air medical transport (helicopter) may provide access to specialized stroke care
when it is not available locally, and such approaches may increase the number of patient who can
be treated especially in rural or otherwise underserved areas (Adams, et al., 2007).
Intravenous thrombolytic therapy for acute stroke is now generally accepted (Adams, et al.,
2007). The US Food and Drug Administration (FDA) approved the use of intravenous rtPA in
1996 on the basis of the NINDS rtPA Stroke Study, in which 624 patients with ischemic stroke
were treated with placebo or rtPA (0.9mg/kg IV, maximum 90 mg) within 3 hours of symptom

16
onset, with approximately one half treated within 90 minutes. Favorable outcomes (defined as
complete or nearly complete neurological recovery 3 months after stroke) were achieved in 31
percent to 50 percent of patients treated with rtPA, as compared with 20 percent to 35 percent of
patients given placebo (Adams, et al, 2007). The major risk of treatment was symptomatic
intracranial hemorrhage, which occurred in 6.4 percent patients treated with rtPA and 0.6 percent
of patients given placebo. The risk of hemorrhage is proportional to the degree to which the
NINDS protocol is not followed (Appendix C).
In 2011 the Brain Attack Coalition published a revision and update of the original 2000
recommendations for the establishment of Primary Stroke Centers (Alberts, et al., 2011). The
update includes a new recommendation that patients with acute stroke be transported to the
nearest facility that can operate as a Primary Stroke Center. The use of telemedicine and air
ambulances may be efficacious for treating and transporting in a rural setting remote from a PSC,
thus allowing the expertise of the PSC to be exported to a remote facility and expediting transfer
of the patient to a PSC (Alberts, et al., 2011). The importance of including EMS in a PSC is
supported by Class I, Level A recommendation. The BAC supports the emergent triage of
patients with stroke to the nearest Stroke Center that can provide appropriate care, and the use of
telemedicine/telestroke/teleradiology as useful components for PSCs that serve as support
hospitals for other facilities in need of such support (Alberts, et al., 2011).
The Institute of Medicine (IOM) of the National Academy of Science has concluded that
the fragmentation of the delivery of healthcare services frequently results in suboptimal
treatment, safety concerns, and inefficient use of healthcare resources. To ensure that scientific
knowledge is translated into practice, the IOM has recommended the establishment of
coordinated systems of care that integrate preventive and treatment services and promote patient
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access to evidence-based care (Schwamm, et al., 2005). The American Stroke Association’s task
force on development of stroke system of care found that although individual components of a
stroke system may be well developed, these components often operate in isolation. The problem
of access to coordinated care may be exacerbated in rural or neurologically underserved
(inadequate access to neurological expertise) areas (Schwamm, et al., 2005). Acute stroke
interventions may be extended to patients in rural and neurologically underserved areas by
establishing consultation and patient transfer protocols. The protocols should include
participation by EMS personnel who are called on to provide inter-facility transport to
appropriate stroke care facilities and support the transport of patients who may receive an
infusion of intravenous rtPA initiated at the referring hospital (Schwamm, et al., 2005).
Statewide assessments of stroke prevention and treatment services were performed in North
Carolina in 1998 and 2003 (Goldstein, 2010). The 2003 survey found certain technologies, but
not stroke-related programs, were more widely available. The survey was repeated in 2008 to
determine whether there was an interval change in accessibility. A 2-page questionnaire was sent
to each North Carolina hospital. Results were compared with the 1998 and 2003 surveys.
Complete responses were obtained from each of the state’s emergent stroke care hospitals. The
use of care maps and intravenous rtPA increased between 2003 and 2008. The proportions of
hospitals having a group of “basic” stroke capabilities did not change (18%, 21 % and 20%
respectively, P>0.05). In 2008, 41 percent of North Carolina’s population resided in a county
with at least 1 Primary Stroke Center and an additional 40 percent in a county using telemedicine
or having a transfer plan for patients with acute stroke (Goldstein, 2010). Many North Carolina
hospitals without the expertise to support hyper-acute interventions used remote
(telephone/telemedicine) support and/or a policy or plan to transfer patients with acute stroke to
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another facility. Nearly 20 percent of the state’s population, however, resided in a county without
a PSC and without a facility that used telephone/telemedicine support or had a standing transfer
plan. The researcher concluded that knowledge of hospitals’ existing resources can help target
facilities for PSC development and those without this potential to develop alternative strategies
such as telemedicine to provide optimal care (Goldstein, 2010).
Process
In 1996, recombinant tissue-type plasminogen activator (rtPA) was approved by the Food
and Drug Administration for ischemic stroke within 3 hours of onset of symptom onset, based on
two randomized phase 3 trials jointly published as the National Institute of Neurological
Disorders and Stroke (NINDS) rtPA Stroke Study( A Evidence) (NINDS, 1995). The NINDS
rtPA stroke study was a double-blind, placebo-controlled study. Preventing and identifying
intracerebral hemorrhage were the foci of patient management both during the rtPA infusion and
in the 24 hours after administration. The original study protocol required that no anticoagulants
or antiplatelet agents be given for 24 hours after treatment and that blood pressure be maintained
within prespecified values (NEJM, 1995). In a special report Dr. Frankel, a principle investigator
for the NINDS rtPA Stroke Study, responded to questions regarding the study protocol and
monitoring regimes (Frankel, 1996). The blood pressure and neurological assessments were
performed every 15 minutes for 2 hours after the infusion was started, then every 30 minutes for
6 hours, and every hour from the eighth hour until 24 hours after the infusion was stopped (Table
1). The original blood pressure treatment regime established by the NINDS rtPA Stroke Study
has been amended since 1996 to include newer pharmaceutical agents (Table 2) (Adams, et al.,
2007). For the purposes of this study it should be noted that in the original rtPA stroke study,
patients were enrolled at one of eight centers and it is not known if any of the rtPA treated
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patients were transferred from a community hospital to a stroke center after the initiation of
intravenous rtPA.
Administration of tissue plasminogen activator (rtPA) for acute ischemic stroke remains
controversial in community practice for a variety of reasons. Well organized hierarchic systems
of acute stroke care have been proposed to link community hospitals to comprehensive stroke
centers. The Maryland Brain Attack Center is a statewide communications and transport network
that provides emergency staff in the state access to stroke specialists. LaMonte and colleagues
(2009) reviewed all Maryland Brain Attack Center consultations for ischemic stroke from 1996
to 2005. Out of the 2,670 consultations and diagnosed 1,788 ischemic stroke patients, two
hundred forty patients (9% of all consultations; and 13.4% of all ischemic stroke patients, were
treated with intravenous rtPA. Patients who were potential candidates were transferred to the
stroke center for care. Initiation of intravenous rtPA was begun before transfer at the community
hospital Emergency Department. Inter-facility transport was provided by Emergency Medical
Services either by ground or by air, depending on the patient condition (LaMonte, et al., 2008).
All patients were transferred to the stroke center and admitted to the medical or neurocare ICU,
where treatment continued according to the stroke protocol modeled after that used in the
NINDS trial (LaMonte, et al., 2008). The percentages of patients with symptomatic intracranial
hemorrhage and 3-month modified Rankin scale scores were less than or equal to 1, compared
with those in the NINDS trial, were as follows: 3.3% versus 6.4% and 53% versus 43% (P=.04).
Mortality rates were 13 percent (network) versus 17 percent (NINDS) (LaMonte et al., 2008).
The researchers concluded the results indicate that the NINDS tPA protocol is applicable to
community practice, with the support of a university-based brain attack center (LaMonte, et al.,
2008).
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In 2006, the North Carolina General Assembly ratified House Bill 1860, which
established a stroke advisory council to provide guidance on the development of a statewide
system of care, including a system for identifying primary stroke centers and disseminate
information about their location (Asimos, Enright, Huston & Mettam, 2010). Quality stroke care
requires expeditious treatment, but several impediments exist. The purpose this study involved a
critical component in the stroke chain of survival – the potential of expeditious ground transport
to hospitals capable of administering high-quality care for acute stroke (Asimos, Enright, Huston
& Mettam, 2010). The study examined the impact of a statewide increase in stroke centers
between 2006 and 2008. They used the drive-time proximity of the residents address to the
nearest Joint Commission Primary Stroke Center (JCPSC) among people who died of stroke as
the outcome. In 2006, 37 percent of geocodable residences of patients who died of stroke (3,834
of 10,469) were within a 40-minute drive from a JCPSC. By the end of 2008, the percentage
increased to 56 percent (3,482 of 6,204). Inclusion of other hospitals that participated in a
recognized quality-improvement program for acute stroke care increased the 40-minute drivetime coverage to 82 percent (5,095 or 6,204) (Asimos, Enright, Huston & Mettam, 2010). The
researchers concluded that the stroke burden is high for many regions of North Carolina and that
timely stroke care is unavailable (Asimos, Enright, Huston & Mettam, 2010). The study did not
consider telestroke support or the use of field-to-hospital helicopter transport, both of which have
the ability to enhance statewide access to experts in acute stroke care.
Many community hospitals do not have a stroke specialist and must rely on telemedicine
or telephone consultation with a stroke neurologist before treating ischemic stroke patients with
intravenous rtPA and transferring to a regional stroke center. Pervez and colleagues (2009)
conducted a retrospective review of the Get with the Guidelines Stroke (GWTG-Stroke) database

21
from 01/2003 to 03/2008 and identified 296 patients who received intravenous rtPA within 3
hours of onset of symptom onset. They analyzed complications and outcomes of patients treated
with intravenous rtPA using the “drip and ship” approach compared to those directly at the
regional stroke center. Of the 296 patients, 181 (61.1%) had rtPA infusion started at an outside
hospital (OSH) and 115 (38.9%) at the regional stroke center (RSC). The patients treated at OSH
were younger with fewer severe strokes than RSC patients. Patients treated via telestroke were
more frequently octogenarians that patients treated based on a telephone consult. Mortality,
symptomatic intracranial hemorrhage, and functional outcomes were not different between OSH
versus RSC and telephone versus telestroke patients (Pervez, et al., 2009). The instruction to
OSH includes post rtPA care management advice. There were no apparent protocol violations in
the determination of eligibility criteria for treatment with intravenous rtPA. Patients were
transferred from hospitals in Massachusetts (n=27 hospitals), New Hampshire (n=5 hospitals),
and Maine (n=1 hospital). The median distance from OSH to the RSC was 43.3 miles with
telestroke hospitals farther away than telephone hospitals 52.2 versus 40 (P=0.005) (Pervez, et
al., 2009). To control for any difference associated with hospital inpatient care processes, they
only included patients treated with intravenous rtPA at an outside hospital if the patient was
transferred to the stroke center. Limitations to the study include no evaluation of inter-facility
transfer adherence to protocol.
Intravenous tissue plasminogen activator for acute ischemic stroke must be provided in
an appropriate setting. According to researchers at the University of Pennsylvania, the best way
to provide thrombolysis small community hospitals remains uncertain (Uchino, Massaro, Jovin,
Hammer & Wechsler, 2010). A retrospective medical record review was conducted of ischemic
stroke patients treated with intravenous rtPA at a stroke center between January 2002 and
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October 2005. The stroke center provides phone consultation for acute stroke to smaller hospitals
in the region. Subjects were classified into 3 groups: intravenous rtPA started at referring
hospitals before transfer (treat and transfer group), intravenous rtPA started at the stroke center
after transfer (transfer and treat group), and the control group of patients who presented directly
to the stroke center and received intravenous rtPA. There were 133 patients in the treat and
transfer group, 35 patients in the transfer and treat group, and 86 patients in the control group.
Fifty-five protocol deviations occurred in 38 percent patients in the treat and transfer group,
compared with 6 percent in the stroke center group (P<.001) (Unchino et al., 2010). The most
common deviations were related to time window violations and incorrect rtPA dosing (Unchino
et al., 2010). The findings indicate a need for improved protocol adherence for stroke
thrombolysis in patients presenting to small community hospitals. The study did not address
protocol adherence by inter-facility transport personnel.
Outcomes
The optimal blood pressure (BP) in stroke remains unclear. For ischemic stroke patients
treated with intravenous thrombolysis, current guidelines suggest pharmacological intervention if
systolic BP exceeds 180 mm Hg (Ahmed, et al., 2009). Researchers from the Department of
Neurology in Stockholm Sweden analyzed the data from a large randomized stroke thrombolysis
clinical trial to determine if there was an association of BP and antihypertensive therapy with
clinical outcomes (Ahmed, et al., 2009). In multivariate analysis, high BP 2 to 24 hours after
thrombolysis was a continuous variable and was associated with poor outcome (P<0.001) and as
a categorical variable had a liner association with symptomatic intracranial hemorrhage (Ahmed,
et al., 2009). Systolic BP > 140 mm Hg is generally accepted as hypertension, therefore it was
categorized as systolic BP >140 mm Hg by each 10 mm Hg. Researchers concluded that the
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higher the systolic BP, the higher the risk of symptomatic intracranial hemorrhage (Ahmed, et
al., 2009).
Hemorrhagic transformation is the most feared and most common complication of
thrombolysis for acute ischemic stroke (Butcher, et al., 2009). The Echoplanar Imaging
Thrombolytic Evaluation Trial (EPITHET) was a randomized, controlled trial of tissue
plasminogen activator (rtPA) or placebo in ischemic stroke patients treated 3 to 6 hours after
onset and who were imaged serially with diffusion (DWI) and perfusion (PWI) weighted
imaging (Butcher, et al., 2009). The aim of the study was to identify predictors of post rtPA
intracranial hemorrhage. Patients were excluded when systolic blood pressure (SBP) was greater
than 185 mm Hg, despite acute treatment, or when they had early ischemic changes on
computerized tomography (CT) involving greater than 1/3 of the middle cerebral territory. All
patients were kept on a cardiac monitor and continuous BP monitor for 24 hours after
randomization. Heart rate and BP were recorded every 15 minutes for 2 hours, every 30 minutes
for 4 hours, hourly for 4 hours, every 2 hours for 8 hours, and then every 4 hours thereafter
(Butcher, et al., 2009). Researchers concluded that arterial pressure during the initial 24 hours
after treatment is associated with rtPA related intracranial hemorrhagic complications. This
finding confirmed that patients treated with intravenous rtPA must have stringent blood pressure
control (Butcher, 2009).
A major concern of physicians, who treat acute ischemic stroke with intravenous rtPA, is
the risk of intracerebral hemorrhage. However, other adverse reactions, including anaphylaxis
and angioedema, can also occur. Angioedema is typically seen in 1 percent to 2 percent of
patients treated with rtPA and may be seen in as many as 5.1 percent of patients if detailed
examination is performed (Khatri, Levine & Jovin, 2008). It is more common in patients on
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angiotensin-converting enzyme inhibitors and in patients with frontal and insular ischemic
infarcts (Khatri, Levine & Jovin, 2008). While the course is usually benign, vigilant monitoring
and treatment are recommended. A suggested protocol from the University of Cincinnati
recommends examination of the tongue 20 minutes before the intravenous rtPA infusion is
complete and repeat examinations several times until 20 minutes after the end of the infusion.
Look for signs of unilateral or bilateral tongue enlargement. If angioedema is suspected, the
algorithm proceeds with pharmacological treatment with antihistamines and corticosteroids. If
angioedema continues emergent airway intubation or tracheostomy may be necessary (Khatri,
Levine & Jovin, 2008). Inter-facility transport personnel should receive training and be prepared
to respond to this emergency.
Ischemic stroke patients are being treated with intravenous rtPA at community hospital
settings with remote consultation by neurology and then being transferred to the closest stroke
center. To date there are no published studies on the inter-facility transport of acute stroke
patients and the association between evidence based protocols and adherence. The purpose of
this study is to measure the protocol adherence during inter-facility transport of acute ischemic
stroke patients treated with intravenous rtPA.
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Chapter III
Methodology
This chapter describes the methodology applied to this study. The design, setting,
population/sampling plan and protection of human subjects are addressed. Additionally, data
collection tools, procedure, data analysis, and analytical assumptions are discussed. The aim of
this study was to measure adherence to acute stroke protocols by transport personnel during
inter-facility transfer of ischemic stroke patients treated with intravenous rtPA. Adherence to
protocol is imperative to reduce the risk of post thrombolysis complications such as intracranial
hemorrhage (Bader & Palmer, 2006). A review of current North Carolina EMS policies,
protocols and procedures was completed as part of the literature review. At present time the
North Carolina Emergency Medical Service has a Suspected Stroke Medical Protocol (Appendix
A), Stroke Destination Plan (Appendix B), a policy for Transport (Appendix C) and a policy for
Air Transport (Appendix D). However, there is no policy or procedure for the management of
stroke patients treated with intravenous rtPA requiring inter-facility transport. This study will aid
in advancing the knowledge base regarding post thrombolysis monitoring and evaluation during
inter-facility transport.
The purpose of the study is to measure the protocol adherence of inter-facility transport
personnel during transport of acute ischemic stroke patients treated with intravenous rtPA.
Setting
The setting for this study was a not-for-profit acute care facility. This institution is a 730
bed acute care facility in western North Carolina. The institution is a Joint Commission certified
primary stroke center serving more than 1.5 million people in eighteen counties of western North
Carolina. The institution is located in the largest city in western North Carolina however the
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service area is predominantly rural. The service area includes sixteen acute care hospitals, five of
which are certified as Critical Access hospitals. The stroke center operates a 24/7/365 hospitalist
neurology program with telephone/telemedicine coverage for hospitals in western North Carolina
and upstate South Carolina. In 2010 the stroke patient volume for the stroke center was 1,185
with 134 stroke patients treated with intravenous rtPA.
Study population
A convenience sampling was used for this study to include all ischemic stroke patients
treated with intravenous rtPA at a western North Carolina hospital and were subsequently
transferred to the primary stroke center between the dates of January 1, 2009 and December 31,
2010.
Inclusion criteria.
The study population included adult subjects (age 18 years and older) that received
intravenous rtPA for acute ischemic stroke at a western North Carolina community hospital and
were transferred to the primary stroke center between the dates of January 1, 2009 and December
31, 2010. The study population included any subjects that developed secondary intracranial
hemorrhage or angioedema post intravenous rtPA.
Exclusion criteria.
The study population excluded all subjects transferred from other states and/or subjects
receiving neuro-interventional treatment at the primary stroke center. The study excluded
subjects with known intracerebral hemorrhage post intravenous rtPA prior to transfer to the
primary stroke center. The study excluded any subject under the age of 18. Subjects with no
inter-facility transport record were excluded from the study. No one was excluded from the study
based on gender or race.
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Data collection and analysis
The study of protocol adherence during inter-facility transport of acute ischemic stroke
patients treated with intravenous rtPA is a quantitative, retrospective, non-experimental analysis
of inter-facility transport documentation. The study received approval from both Gardner-Webb
University’s Institutional Review Board (IRB) and the study facility’s IRB prior to data
collection and analysis.
The primary stroke center maintains a database of all patients transferred to the stroke
center. A query was conducted to select all ischemic stroke patients treated with intravenous
rtPA transferred to the stroke center between January 1, 2009 and December 31, 2010. The study
subject list was validated using the principle diagnosis ICD9 codes 433 or 434 and a secondary
V-code of V45.88. The secondary V-code V45.88 was created in 2008 by the Center for
Medicare and Medicaid (CMS) for the purposes of tracking all patients that receive intravenous
rtPA within 24 hours of transfer to a tertiary care hospital (Tonarelli, 2010).
A data abstraction tool was created to include subject characteristics (age, gender and
referring institution), time of rtPA initiation, time and duration of inter-facility transport,
frequency of documented blood pressure and neurological assessment during transport, 24 hour
CT or MRI results and subject discharge disposition. Subject identification will be the medical
record number. The medical record abstraction will include access to referring hospital records
that accompanied the subject at the time of transfer and records from the inter-facility transport
team (EMS, Critical Care transport or Air medical transport). The researcher contacted the
transporting agency via email to secure any missing documentation to ensure adequate
representation of all transferred subjects. The transporting agency was asked to fax a deidentified record to a secure fax machine located in the primary stroke center administrative
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office. Subjects with no inter-facility transport documentation were excluded from the study
population.
For the purposes of this study protocol adherence was defined as documentation of blood
pressure and neurological assessment with expected intervals determined by the time of initiation
of intravenous rtPA.
IBM SPSS Statistics 19 was used for analysis. Both descriptive and inferential statistics
were utilized to address the following research questions.
1. What are the demographic characteristics of the study population?
2. What is the association between travel time and adherence to protocol?
3. What is the association between time of day on adherence to protocol?
4. What is the association between type of transport agency on adherence to protocol?
5. Is there a correlation between protocol adherence and discharge disposition?
6. Is there a correlation between protocol adherence and time of completion of
intravenous rtPA?

Consent and protection of human subjects
Informed consent was not required as no subject names were recorded and there was no
contact with the subjects. The data collection forms will remain secured in a locked cabinet in
the researcher’s office. At the end of six years research data will be destroyed.
Summary
This chapter describes the research methodology that provided the statistical framework
for this study. The setting and sample were also described, as well as the protection of the human
rights of the participants. Analyses and study findings are presented in Chapter 4.
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Chapter IV
Results
The study of protocol adherence during inter-facility transport of acute ischemic stroke
patients treated with intravenous rtPA is a quantitative, retrospective, non-experimental analysis
of inter-facility transport documentation. The purpose of this chapter is to present and discuss the
results of this study. To facilitate the reader’s understanding, the discussion of the findings and
presentations are organized in relation to the research questions and as each relates to the
framework of structure, process and outcome.
Description of the sample
The sample was a convenience sample of all ischemic stroke patients treated with
intravenous rtPA and transferred to the primary stroke center between the dates of January 1,
2009 and December 31, 2010. The study subjects were selected using the stroke center database
and validated using the principle diagnosis ICD9 codes 433 or 434 and a secondary V-code of
V45.88. The initial query yielded a potential pool of seventy-four subjects. Of these, fourteen
were excluded due to transfer from facilities outside of North Carolina, one was excluded due to
transfer ensued after the development of a post intravenous rtPA related intracranial hemorrhage
and fourteen were excluded due to no inter-facility transport documentation available to the
researcher. The final study population was forty five subjects with principle diagnosis of
ischemic stroke that were treated with intravenous rtPA at a North Carolina hospital and
transferred to the primary stroke center between the dates of January 1, 2009 and December 31,
2010.
Research question one evaluates the study population (structure) and was addressed
descriptively. The study population was evenly distributed with slightly higher number of males.
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The mean age for entire sample was 71.3 with SD 11.5. The mean age was 70 and 72 for males
and females respectfully. The range was 48 with minimum age of 45 years to maximum age of
93 years. Table 1 illustrates the description of the demographic factors of the population.
Table 1
Study population demographics n=45
Gender
Frequency
Male
24
Female
21

Percentage
53.3
46.7

Mean Age
70
72

Research question two inquired of the nature of the association between distance of travel
(structure) and the adherence to protocol (outcome). To answer this question descriptive statistics
were utilized to describe the referral hospitals, the mode of inter-facility transport and the time to
complete transportation between referral hospital and receiving hospital. Table 2 presents data
pertaining to the referral hospital demographics. All referral hospitals are community based and
not-for-profit. The type indicates the designation of Critical Access Hospital (CAH). The
frequency and percentage volumes refer to rate of inter-facility transfers specific to the study
population. The majority of transfers (44.5%) were from 3 hospitals (Referral Hospitals A, E,
and K), two of these are designated CAH. The frequency range was from a minimum of 1
transfer to a maximum of 8. Table 3 outlines the transport time as “door-to-door” mean time for
each type of transportation.
Figure 2 displays the distance in miles and was calculated for one-way transport between
the referral hospital and the stroke center. The distance between facilities ranges from a
minimum of 20.4 miles to a maximum of 110.4 miles.
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Table 2
Referral hospital characteristics
Referral Hospital

Critical Access
Designation

Frequency

Percentage

A

Yes

7

15.6

B

No

6

13.3

C

No

1

2.2

D

No

3

6.7

E

No

8

17.8

F

No

2

4.4

G

No

1

2.2

H

No

2

4.4

I

No

3

6.7

J

Yes

1

2.2

K

Yes

5

11.1

L

No

3

6.7

M

Yes

2

4.4

N

No

1

2.2
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Figure 2: Inter-facility one-way mileage

Inter-facility one-way mileage
120
110.4
100
80

79.8
68.7

66.2

65.9

63.1

60

54.2

51.7
40
26.7

20

34.4

26.6

46.6
28.5

20.4

0
A

B

C

D

E

F

G

H

I

J

K

L

M

N

The mode of inter-facility transport for the study population was either by county level
Emergency Medical Services (EMS), the receiving hospital-based critical care transport truck or
the receiving hospital-based air medical service (helicopter). The referral hospital physician
determines the most appropriate mode of transport based on both the urgency for a timely
transfer and the appropriate level of monitoring required during inter-facility transport. Figure 3
presents the data regarding the mode of transport utilized by referral hospital.
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Figure 3: Mode of transportation by referral hospital
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The transport time was derived by calculating the time of departure from the referral
hospital to the time of arrival at the receiving facility. The door-to-door time in minutes ranged
from a minimum of 12 minutes to a maximum of 131 minutes. The door-to-door time was
significantly shorter for the air medical transport (P<.005). Table 3 presents the mean and SD
times for each transportation type. Drive times reflect the variation in distance between referral
hospitals and the receiving facility.
Table 3
Door to Door Transport Times
Mode
Number
EMS
23
Critical Care
16
Air Medical
6

Mean
48.61
67.69
24.33

Minimum
19
24
12

Maximum
119
131
56

Std D
27.820
29.309
16.108

Door-to-door transport time was compared to protocol adherence. The findings were not
significant but point to the conclusion that shorter transport times correlate with increased
protocol adherence. Figure 4 and 5 compares transport time to protocol adherence. Protocol
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adherence was present for transport times less than 60 minutes 65% versus protocol adherence
for transport times greater than or equal to 60 minutes at 37%.

Figure 4: Protocol adherence related to transport time greater or equal to 60 minutes

Percentage Protocol Adherence
Transport Time greater or equal to 60 minutes

37%
Yes
No

63%

Figure 5: Protocol adherence related to transport time less than 60 minutes
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Research questions three through five reflect on how structure and process affect the
adherence to protocol or outcome. The descriptive analysis presents that in 55.6% of all study
cases the transporting agency did adhere to the monitoring protocol.
Research question three inquired as to the effect of time of day on adherence to the
protocol. To evaluate this variable the time of day was sub-divided into two separate time
periods: 1) day shift (DS) from 0800 to midnight and 2) night shift (NS) from midnight to 0800.
The rationale for the time selection was based on EMS and transport providers’ work 24 hour
shifts at a time and time of day may have a direct association with adherence to protocol. The
majority of the transports occurred during the DS (91.1%) with only four cases (8.9%)
transferred during the NS. No statistical significance demonstrated based on small sample size.
Table 4
Transport shift and protocol adherence
Transport Shift
DS 0800 – midnight

NS midnight - 0800

Protocol
adherence
Yes

Frequency

Percent

24

58.5

No

17

41.5

Yes

1

25

No

3

75

Research question four inquired the association between the type of transport agency
provider and protocol adherence. Correlations related to the type of transport and the components
of a protocol adherence were calculated to determine if adherence differed among groups. A Chi
Square statistic was conducted on the frequencies per agency type. The air medical service level
demonstrated protocol adherence 83.3% of all air medical transports. However, the results were
not statistically significant due to the small sample size. Table 5 compares adherence by
transport type.
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Table 5
Protocol adherence related to transport type
Transport type
Protocol adherence
EMS
Critical Care
Air Medical

Frequency

Percent

11
12
9
7
5
1

47.8
52.2
56.3
43.8
83.3
16.7

Yes
No
Yes
No
Yes
No

Research question five inquired as to the effect of the process on discharge disposition. A
cross tabulation of adherence to protocol to discharge disposition using Chi Square was not
statistically significant due to the small sample size. There was a noted tendency towards
significance with 100% positive adherence to protocol in the subjects discharged to a skilled
nursing facility or expired. Table 6 lists the percentages based on discharge disposition.

Table 6
Percent protocol adherence for discharge disposition
Protocol
Home
Home
Acute
adherence
Health
Rehab
Yes
41.2
75
57.1
No
58.8
25
42.9

Hospice
40
60

Skilled
Nursing
100
0

Expired
100
0

An additional outcome marker to consider would be the incidence of post thrombolytic
(rtPA) intracranial hemorrhage. There was one case with a documented asymptomatic
intracranial hemorrhage noted on the CT scan performed at 24 hours post intravenous rtPA. This
equals a 2.2% hemorrhage rate which is lower than the original NINDS reported rate of 6%
(Alberts et al, 2008). Non-adherence to protocol has been associated with post thrombolytic
intracranial hemorrhage and the one case in the study sample was associated with non-adherence.
A cross tabulation Chi Square statistic was conducted on the frequencies of 24 hour ICH in
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relation to protocol adherence. A continuity correction was computed for a 2x2 table with
P=.013 and is not considered statistically significant.
There was no documented incidence of post rtPA associate angioedema or oro-lingual
edema in the study population. One subject did require emergency oral intubation for respiratory
distress. The intubation was completed by the EMS paramedic en route to the stroke center.
Research question six evaluated the association between the time of completion of
intravenous rtPA and protocol adherence. The time of intravenous rtPA completion was derived
from calculating the time of initiation as documented by the referral hospital and a standard
infusion time of 60 minutes. The frequency of inter-facility transport with intravenous rtPA
infusing occurred in 25 of the cases for a percentage rate of 55.6%. A Chi Square statistic was
conducted on the frequency of rtPA infusing en route by transport type with P=.004. A cross
tabulation Chi Square statistic was conducted on the frequencies of rtPA infusing en route and
protocol adherence. The results showed a positive trend for protocol adherence when intravenous
rtPA is infusing en route. The continuity correction value was computed for a 2x2 table and with
P<.001 and this was considered statistically significant.
This study provided a snapshot of the demographics of a convenience sample of ischemic
stroke patients from western North Carolina who were treated with intravenous rtPA at the local
community hospital and were subsequently transferred to the stroke center. The constructs of
structure, process and outcome were applied to the relationships between inter-facility transport
personnel and protocol adherence. A statistical finding was identified between the presence of
intravenous rtPA infusing during transport and protocol adherence. A discussion of factors that
could have had an effect of the outcomes of this study is presented in Chapter 5.
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Chapter V
Discussion
Significance of the Findings
The purpose of this study was to evaluate the structure, process and outcomes related to
the inter-facility transport of ischemic stroke patients treated with intravenous rtPA. The study
was conducted on a convenience sample of all ischemic stroke patients treated with intravenous
rtPA in a North Carolina hospital and transferred post treatment to the stroke center within 24
hours of intravenous rtPA. The study correlated structural and process components (type of
transport, time of transport, and adherence to protocol) in relation to patient outcomes (presence
of post rtPA intracerebral hemorrhage and discharge disposition).
The study sample size was considered too small to support statistical significance.
However, the sample demonstrated the variation in terms of age, community and transport type.
Low volumes with potential high risk such as this type of patient situation support the need for a
protocol or guideline to reduce the likelihood of preventable complications. The discovery that
North Carolina does not have a standard policy or guideline pertaining to inter-facility transport
of ischemic stroke patients treated with intravenous rtPA was the most significant finding of this
study. The evidence strongly supports strict adherence to blood pressure guidelines and
neurological assessment for ischemic stroke patients treated with intravenous rtPA (Bader &
Palmer, 2006).
A statistical finding from the study supports that air medical transport is the fastest mode
of transportation from the referring hospital to the receiving hospital. For those patients needing
additional treatment intervention at the stroke center the referring facility should consider air
medical transport. The study findings suggest that shorter transport times increase the likelihood
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of protocol adherence by all transport types, 65.5% protocol adherence if less than 60 minutes
compared to 37.5% protocol adherence if greater than or equal to 60 minutes for transport. The
shorter transport times reduces the expected frequency of serial assessments.
The relationship between protocol adherence and discharge disposition was not
statistically significant. The finding suggests a correlation between protocol adherence and
discharge status to skilled nursing facility or expired in the hospital. This correlation may
indicate that stroke severity at the time of transport prompts more frequent re-assessments.
The study findings support a direct correlation between the continuance of intravenous
rtPA during transport and positive protocol adherence. This suggests that medical personnel are
more aware of the risks associated with thrombolytic use (rtPA) and when present they are more
diligent with performing and documenting patient assessment.
Implications for Nursing Practice
Duffy’s Quality-Caring Model© combines evidence-based practice while simultaneously
representing nursing’s unique contribution to quality health care. . Inherent in the Quality-Caring
Model© is the continuous search for evidence that care provided does in fact benefit patients.
Nurses’ are responsible for assuring the patient’s safe transition of care from one provider to
another and from one facility to another. The implications for nursing practice include the
development and dissemination of a post thrombolytic monitoring and assessment protocol to be
used by nursing and inter-facility transport personnel. The study highlighted the fact that this is
not an everyday occurrence in most emergency departments; this infrequent occurrence
necessitates the need for standardization and clearly defined monitoring parameters and
protocols.
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Limitations of the study
Several limitations were identified for this study. It is North Carolina EMS policy that all
patient transports are documented and a copy of such is provided to the receiving hospital,
however, the documentation may be limited to one-page brief description of the inter-facility
transport. Fourteen potential subjects were excluded from the study because no record of interfacility transport was accessible by the researcher. The sample size was too small to produce
statistically significant correlations and these fourteen cases would have added valuable
information. The ideal situation would be to have the inter-facility transport documentation at the
time of transport to facilitate communication and patient transition of care.
The study findings were limited to the available data. Outcome measurements were
limited to the data available such as discharge disposition and post thrombolytic complications.
The documentation of the patient’s baseline neurologic deficit was limited and in some cases not
available. The study did not include the stroke severity.
Other statistical limitations were related to the small sample size. The sample was limited
to only those patients who received intravenous rtPA and were transferred to the stroke center.
Application of the data may be limited to a similarly selected population of acute stroke patients
who received stroke specialty consultation.
Recommendations for future research
A subsequent study that follows the development and implementation of an inter-facility
transfer guideline for EMS transport personnel should be considered in order to compare preand post- implementation outcomes. The patients should be evaluated at baseline using the NIH
Stroke Scale and Modified Rankin Score to document baseline neurologic and functional ability.
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Importance of the findings for nursing
Nurses are often responsible for the coordination of care throughout the continuum.
Optimal management of the acute ischemic stroke patient in the emergency phase of care
requires an accurate and systematic evaluation that is coordinated and timely. Nurses have a
unique role in improving patient outcomes. Adherence to evidence-based protocols can be
accomplished through comprehensive planning and preparation. Research is paramount to
understanding of how structure and process impact outcomes.
To positively affect patient outcomes all stroke care providers must be knowledgeable of
evidence-based guidelines. In many community and academic institutions, education of EMS
providers has become a function of the nurse educator. Before beginning an EMS stroke
education program, the nurse educator should verify local policies and regulations governing
acceptable practice for paramedics and EMTs for the region or state. Continuing education of
EMS personnel is challenging requiring frequent updates. As a part of their continuing
education, EMS personnel must be provided with accurate information regarding acute stroke
guidelines and protocols. Stroke education should emphasize that inter-facility transport of the
stroke patient treated with intravenous rtPA requires priority status and includes serial
monitoring of vital signs and neurological status.

42
References
Adams, H.P., del Zippo, G., Alberts, M. J., Bhatt, D. L., Brass, L., Furan, A. …Wijdicks, E.F.M.
(2007). Guidelines for the early management of adults with ischemic stroke: A guideline
from the American Heart Association/American Stroke Association stroke council,
clinical cardiology council, cardiovascular radiology and intervention council, and the
atherosclerotic peripheral vascular disease and quality of care outcomes in research
interdisciplinary working groups. Stroke 38 1655-1711.
Adeoye, O. Hornung, R., Khatri, P., & Kleindorfer, D. (2011). Recombinant tissue-type
plasminogen activator use for ischemic stroke in the United States. Stroke 42 1952-1955.
doi:10.1161/STROKEAHA.110.612358.
Ahmed, N., Wahlgren, N., Brainin, M., Castillo, J., Ford, G.A., Kaste, M….Danilo, T. (2009).
Relationship of blood pressure, antihypertensive therapy, and outcome in ischemic stroke
treated with intravenous thrombolysis. Stroke 40 2442-2449.
doi:10.1161/STROKEAHA.109.5480602.
Alberts, M.J., Latchaw, R.E., Jagoda, A., Wechsler, L.R., Crocco, T., George, M.G.,…Walker,
M.D. (2011). Revised and updated recommendations for the establishment of primary
stroke centers: A summary statement from the Brain Attack Coalition. Stroke, 42, 26512665. doi:10.1161/STROKEAHA.111.615336
Alberts, M.J., Felberg, R.A., Guterman, L.R., & Levine, S.R. (2008). Atherosclerotic peripheral
vascular disease symposium II stroke intervention: State of the art. Circulation 118,
2845-2851. doi:10.1161/CIRCULATIONAHA.108191174.
Arora, S., Broderick, J.P., Frankel, M., Heinrich, J.P., Hickenbottom, S., Karp, H., LaBresh,
K.A.,…Weiss, P. (2005). Acute stroke care in the US: Results from 4 pilot prototypes of

43
the Paul Coverdell national acute stroke registry. Stroke 36, 1232-1240.
doi:10.1161/01.STR.000016590218021.5b.
Asimos, A.W., Enright, D., Huston, S.L., & Mettam, L.H. (2010). Drive-time proximity to joint
commission primary stroke centers among North Carolina residents who died of stroke.
North Carolina Medical Journal 71(5) 413-420.
Bader, M.K., & Palmer, S. (2006). What’s the “hyper” in hyperacute stroke? AACN Advanced
Critical Care 17(2) 194-214.
Bambauer, K.Z., Johnston, S.C., Bambauer, D.E. & Zivin, J.A. (2006). Reasons why few
patients with acute stroke receive tissue plaminogen activator. Archives Neurology 63(5)
661-664.
Bledsoe, B.E., Porter, R.S., & Cherry, R.A. (2009) Paramedic care principles & practice:
Introduction to advanced prehospital care (pp. 50-69). New Jersey: Pearson Prentice
Hall.
Butcher, K., Christensen, S., Parsons, M., De Silva, D.A., Ebinger, M., Levi, C….Davis, S.M.
(2009). Postthrombolytic blood pressure elevation is associated with hemorrhagic
transformation. Stroke 41 72-77. doi:10.1161/STROKEAHA.109.563767.
Caplan, L.R. (2000). Caplan’s stroke, a clinical approach 3rd ed. (pp. 17). Boston: ButterHeineman
Chin, M.H. & Muramatsu, N. (2003). What is the quality of quality medical care measures?
Rashomon-like relativism and real-world applications. Perspectives in Biology and
Medicine 46(1) 5-20.
Duffy, J. R.& Hoskins, L. M. (2003). The Quality-Caring Model: Blending dual paradigms.
Advances in NursingScience 26 (1):77-88.

44
Duffy, J.R. (2005). Implementing the quality-caring model in acute care. Journal of Nursing
Administration 35(1) 4-6.
Duffy, J., R., Baldwin, J., Mastorovich, M.J., (2007). Using the quality-caring model to organize
patient care delivery. Journal of Nursing Administration 37(12) 546-551.
Fonarow, G.C., Smith, E.E., Saver, J.L., Reeves, M.J., Hernandez, A.F., Peterson, E.D.,
…Schwamm, L.H. (2011). Improving door-to-needle times in acute ischemic stroke: The
design and rationale for the American Heart Association/American Stroke Association’s
target: Stroke initiative. Stroke 42 2983-2989.
Frankel, M.R. (1996). The use of intravenous tissue-plasminogen activator for acute ischemic
stroke: Questions and answers on the NINDS t-PA stroke study. The Neurologist 2(000)
1-9.
Goldstein, L.B. (2010) Statewide hospital-based stroke services in North Carolina: Changes over
10 years. Stroke 41 778-783. doi:10/1161STROKEAHA.109.572750.
Johnson, M. & Bakas, T. (2010). A review of barriers to thrombolytic therapy: Implications for
nursing care in the emergency department. Journal of Neuroscience Nursing 42(2) 88-94.
Khatri, P., Levine, J., & Jovin, T. (2008). Intravenous thrombolytic therapy for acute ischemic
stroke. Continuum: Lifelong Learning Neurology 14(6) 46-60.
LaMonte, M.P., Bahouth, M.N., Magder, L.S., Alcorta, R.L., Bass, R.R., Browne, B.J….Gaasch,
W.R. (2008). A regional system of stroke care provides thrombolytic outcomes
comparable with the NINDS stroke trial. Annals of Emergency Medicine 54(3) 319-327.
doi:10.1016/j.annemergmed.2008.09.022.

45
The National Institute of Neurological Disorders and Stroke rtPA Stroke Study Group (1995).
Tissue plasminogen activator for acute ischemic stroke. New England Journal of
Medicine 333(24) 1581-1587.
Pervez, M.A., Silva, G., Masrur, S., Betensky, R.A., Furie, K.L., Hidalgo, R….Schwamm, L.H.
(2009). Remote supervision of IV-tPA for acute ischemic stroke by telemedicine or
telephone before transfer to a regional stroke center is feasible and safe. Stroke 41e18e24. doi:10.1161/STROKEAHA.109.560169.
Rafter, R.H. & Kelly, T.M. (2011). Nursing implementation of a telestroke programme in a
community hospital in the US. Journal of Nursing Management 19 193-200. doi:
10.1111/j.1365-2834.2011.01233.x.
Rosamond, W., Flegal, K., Furie, K., Go, A., Greenlund, K., Haase, N….Hong, Y. /j.(2008).
Heart disease and stroke statistics 2008 update: A report from the American Heart
Association statistics committee and stroke statistics subcommittee. Circulation 117 e25e146. doi:10.1161/CIRCULATIONAHA.107.187998.
Schwamm, L.H., Holloway, R.G., Amarenco, P., Audebert, H.J., Bakas, T., Chumler, N.R.,
Handschu, R.,…Wechsler, L.R. (2009). A review of the evidence for the use of
telemedicine within stroke systems of care. Stroke 40 2616-2634.
doi:10.1161/STROKEAHA.109.192360.
Schwamm, L.H., Pancioli, A., Acker III, J.E., Goldstein, L.B., Zorowitz, R.D., Shephard,
T.J….Adams, R.J. (2005). Recommendations for the establishment of stroke systems of
care: Recommendations from the American Stroke Association’s task form on the
development of stroke systems. Stroke 36 690-703.
doi:10.1161/01.STR.000015865.42884.4F.

46
Summers, D., Leonard, A., Wentworth, D., Saver, J.L., Simpson, J, Spilker, J.A.,…Mitcherll,
P.H. (2009). Comprehensive overview of nursing and interdisciplinary care of the acute
ischemic stroke patient: A scientific statement from the American Heart Association.
Stroke 40 2911-2944. doi: 10.1161/STROKEAHA.109.192362.
Tonarelli, S.B., Tibbs, M.,Vazquez, G., Lakshminarayan, K.,Rodriguez, G.J. & Qureshi, A.I.
(2010) Accuracy of the new ICD-9-CM code for “drip-and-ship” thrombolytic treatment
in patients with ischemic stroke. Journal of Stroke & Cerebrovascular Diseases 19(5)
doi: 10.1016/j.jstrokecerebrovasdis.2010.05.011.
Uchino, K., Massaro, L., Jovin, T.G., Hammer, M.D., & Wechsler, L.R. (2010) Protocol
adherence and safety of intravenous thrombolysis after telephone consultation with a
stroke center. Journal of Stroke & Cerebrovascular Diseases 19(6) 417-423.

47
Appendices
Appendix A: Patient Management After rtPA Administration (Frankel, 1996)


No anticoagulants or antiplatelets agents for 24 hours



Blood pressure monitoring for the first 24 hours: every 15 minutes for 2 hours after
starting the infusion, every 30 minutes for 6 hours, then every hour from the eighth
hour until 24 hours after rtPA started



Aggressive blood pressure management to maintain BP <185/110 mm Hg
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Appendix B: Approach to Hypertension in Acute Ischemic Stroke (Adams, et al., 2007)

During/after treatment
1. Monitor blood pressure


Check blood pressure every 15 min for 2 h, then every 30 min for 6 h, and finally
every hour for 16 h

2. Diastolic greater than 140


Sodium nitroprusside 0.5 mcg/kg/min IV infusion as initial dose and titrate to
desired blood pressure

3. Systolic greater than 230 OR diastolic 121 – 140.


Option 1


Labetalol 10 mg IV for 1 - 2 min



May repeat or double labetalol every 10 min to maximum dose of 300
mg, or give initial labetalol dose, then start labetalol drip at 2 - 8 mg/min



Option 2


Nicardipine 5 mg/h IV infusion as initial dose and titrate to desired effect
by increasing 2.5 mg/h every 5 min to maximum of 15 mg/h; if blood
pressure is not controlled by labetolol or nicardipine, consider sodium
nitroprusside.

4. Systolic 180 - 230 OR diastolic 105 - 120


Labetalol 10 mg IV for 1 - 2 min

May repeat or double labetalol every 10 - 20 min to maximum dose of 300 mg or give
initial labetalol dose, then start labetalol drip at 2 - 8 mg/min
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Appendix C: North Carolina EMS Protocol for suspected stroke
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Appendix D: North Carolina EMS stroke destination plan
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Appendix E: North Carolina EMS transport policy
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Appendix E: North Carolina Air Transport policy

